Entry into or termination of material definitive agreements (Items 1.01/1.02).
Lomond Therapeutics Holdings, Inc. entered into Series A Preferred Unit Purchase Agreement with Idwal Therapeutics, LLC valued at approximately $9.0 million (effective 2026-01-08).
“On January 8, 2026, Lomond Therapeutics Holdings, Inc. (the “Company”) entered into a Series A Preferred Unit Purchase Agreement (the “Purchase Agreement”)”
Pelthos Therapeutics Inc. entered into Venture Loan and Security Agreement with Horizon Technology Finance Corporation valued at aggregate principal amount of up to $50.0 million (effective 2026-01-12).
“On January 12, 2026 (the “ Closing Date ”), Pelthos Therapeutics Inc., a Nevada corporation (the “ Company ”), LNHC, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“ LNHC ”) and Channel Pharmaceutical Corporation, a Nevada corporation and a wholly subsidiary of the Company (“ Channel ”), as co-borrowers (together with the Company, the “ Borrowers ”), entered into a Venture Loan and Security Agreement (the “ Loan Agreement ”) by and among the Borrowers and Horizon Technology Finance Corporation, a Delaware corporation, as lender and collateral agent (the “ Lender ”).”
Mountain Lake Acquisition Corp. amended First Amendment with Astral Horizon, L.P., Dragonfly Ventures L.P., Dragonfly Ventures, II L.P. (effective 2026-01-13).
“on January 13, 2026, SPAC, Pubco, the Pubco Subsidiaries, the Company and the Seller entered into that certain Amendment No. 1 to Business Combination Agreement (the “ First Amendment ”) with Astral Horizon, L.P., a Delaware limited partnership (“ Astral ”), Dragonfly Ventures L.P., a Cayman Islands exempted limited partnership (“ DV ”), and Dragonfly Ventures, II L.P., a Cayman Islands exempted limited partnership”
Willow Lane Acquisition Corp. amended Amendment No. 1 to the Business Combination Agreement with Boost Run Inc., Benchmark Merger Sub I Inc., Benchmark Merger Sub II LLC, Boost Run Holdings, LLC, George Peng, Andrew Karos valued at Amendment No. 1 to the Business Combination Agreement (effective 2026-01-13).
“On January 13, 2026, the parties to the Business Combination Agreement entered into Amendment No. 1 to the Business Combination Agreement (the “Amendment No. 1 to the Business Combination Agreement”), which amends the Business Combination Agreement to, among other things, extend the Outside Date (as defined in the Business Combination Agreement) to June 30, 2026, and remove the covenant that the post-closing Pubco board be comprised of a majority of directors who qualify as “independent” under Nasdaq rules.”
Resolute Holdings Management, Inc. entered into Management Agreement with Husky Holdings.
“an indirect subsidiary of the CompoSecure, Inc. that will hold, directly or indirectly, the business of Husky following the closing (“Husky Holdings”), entered into a management agreement (the “Management Agreement”) with us on the Closing Date”
Digital Asset Acquisition Corp. entered into Business Combination Agreement with Old Glory Holding Company (effective 2026-01-13).
“On January 13, 2026, Digital Asset Acquisition Corp., a Cayman Islands exempted company (“DAAQ”), entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), with Old Glory Holding Company, a Delaware corporation, registered as a Bank Holding Company under the Bank Holding Company Act of 1956 (“Old Glory Bank”).”
D. Boral ARC Acquisition I Corp. entered into Agreement and Plan of Merger with Exascale Labs Inc. valued at $500,000,000 (effective 2026-01-11).
“On January 11, 2026, D. Boral ARC Acquisition I Corp. (“BCAR” or the “Company”) entered into the Agreement and Plan of Merger (the “Merger Agreement”) by and among BCAR, D. Boral ARC Merger Corporation, a Delaware corporation and wholly owned subsidiary of BCAR (“PubCo”), D. Boral Arc Merger Sub Inc. (“Merger Sub”), a Delaware corporation and a wholly-owned subsidiary of BCAR, and Exascale Labs Inc.., a Delaware corporation (“Exascale”).”
Lafayette Digital Acquisition Corp. I entered into Private Units Subscription Agreement with BTIG (effective 2026-01-08).
“Agreement, dated January 8, 2026, by and between the Company and BTIG, LLC, as representative of the underwriters in the IPO (“BTIG”), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference; ● Warrant”
Lafayette Digital Acquisition Corp. I entered into Private Units Subscription Agreement with the Sponsor (effective 2026-01-08).
“Units Subscription Agreement, dated January 8, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by reference; ● Private”
Lafayette Digital Acquisition Corp. I entered into Underwriting Agreement with BTIG, LLC (effective 2026-01-08).
“Underwriting Agreement, dated January 8, 2026, by and between the Company and BTIG, LLC, as representative of the underwriters in the IPO (“BTIG”)”
DELTA AIR LINES, INC. entered into a asset purchase with The Boeing Company (effective 2026-01-12).
“On January 12, 2026, Delta Air Lines, Inc. (“Delta”) entered into a definitive agreement with The Boeing Company to acquire 30 Boeing 787-10 aircraft, with an option to purchase up to an additional 30 of the same aircraft.”
TANGER PROPERTIES LTD PARTNERSHIP /NC/ entered into Indenture with U.S. Bank Trust Company, National Association, as trustee valued at $250 million (effective 2026-01-12).
“The Notes and the Guarantee were issued pursuant to an indenture, dated as of January 12, 2026 (the “Indenture”), among the Operating Partnership, the Company and U.S. Bank Trust Company, National Association, as trustee”
TANGER PROPERTIES LTD PARTNERSHIP /NC/ entered into Purchase Agreement with BofA Securities, Inc. (the "Representative"), as representative of the several initial purchasers valued at $250 million (effective 2026-01-07).
“the Operating Partnership and the Company entered into a Purchase Agreement dated January 7, 2026 (the “Purchase Agreement”) with BofA Securities, Inc. (the "Representative"), as representative of the several initial purchasers named therein”
GLOBAL PAYMENTS INC entered into Registration Rights Agreement with GTCR.
“Shareholders Agreement As a result of the Transactions, GTCR now holds approximately 15.45% of the outstanding shares of Global Payments Common Stock based upon the outstanding shares of Global Payments Common Stock”
GLOBAL PAYMENTS INC entered into Shareholders Agreement with GTCR.
“Shareholders Agreement As a result of the Transactions, GTCR now holds approximately 15.45% of the outstanding shares of Global Payments Common Stock based upon the outstanding shares of Global Payments Common Stock”
CVRx, Inc. amended Amendment with Innovatus Life Sciences Fund I, LP valued at $50 million (effective 2026-01-09).
“On January 9, 2026 (the “Closing Date”), CVRx, Inc. (the “Company”) entered into an amendment (the “Amendment”) to its existing Loan and Security Agreement dated October 31, 2022, as previously amended on March 13, 2023 (as amended, the “Loan Agreement”), among the Company, Innovatus Life Sciences Fund I, LP, as the collateral agent and a lender, and the other lenders from time to time party thereto.”
CVRx, Inc. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $50.0 million (effective 2026-01-12).
“On January 12, 2026, CVRx, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sale Agreement”) with Jefferies LLC (the “Agent”).”
QXO, Inc. entered into Investment Agreement with AP Quince Holdings, L.P. and other investors valued at aggregate purchase price of $3.0 billion (effective 2026-01-12).
“On January 12, 2026, QXO, Inc. (“QXO” or the “Company”) and certain new investors entered into joinders to the Investment Agreement, dated as of January 5, 2026 (the “Investment Agreement”), among AP Quince Holdings, L.P., a fund managed by affiliates of Apollo Global Management, Inc., and the other investors party thereto (collectively, the “Convertible Preferred Investors”).”
ARES CAPITAL CORP entered into Fifth Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $750,000,000 (effective 2026-01-12).
“On January 12, 2026 Ares Capital Corporation (the “Company”) and U.S. Bank Trust Company, National Association (the “Trustee”), entered into a Fifth Supplemental Indenture (the “Fifth Supplemental Indenture”) to the Indenture, dated May 13, 2024, between the Company and the Trustee (the “Base Indenture” and, together with the Fifth Supplemental Indenture, the “Indenture”).”
Amphastar Pharmaceuticals, Inc. amended Manufacturing Amendment with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. valued at Change in value not determinable; expands territory globally except US and Canada for Lidocaine and (effective 2026-01-06).
“On January 6, 2026, Amphastar Nanjing Pharmaceuticals, Inc., the Chinese subsidiary of Amphastar and Hanxin entered into an amendment to the Manufacturing Agreement (the “Manufacturing Amendment”), originally entered into on April 19, 2022, as previously reported by the Company on a Current Report on Form 8-K filed on April 22, 2022.”
Amphastar Pharmaceuticals, Inc. amended Distribution Amendment with Hong Kong Genreach Limited valued at Change in value not determinable; expands region with additions of Middle East and Southeast Asian c (effective 2026-01-06).
“On January 6, 2026, Armstrong Pharmaceuticals, Inc. a wholly-owned subsidiary of the Amphastar and Hong Kong Genreach Limited (“Genreach”) a wholly-owned subsidiary of Hanxin entered into an amendment to the Distribution Agreement (the “Distribution Amendment”), originally entered into on August 28, 2024, as previously reported by the Company on a Current Report on Form 8-K filed on August 30, 2024 (the “Distribution Agreement”).”
Amphastar Pharmaceuticals, Inc. entered into License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. valued at Amphastar made an upfront payment of $2 million; development milestone payments up to $14 million; s (effective 2026-01-06).
“On January 6, 2026, Amphastar Pharmaceuticals, Inc (“Amphastar” or, the “Company”), and Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (“Hanxin”), entered into a License Agreement (“License Agreement”) pursuant to which Hanxin is granting an exclusive license to certain intellectual property controlled by Hanxin to develop, make, use and commercialize products incorporating or comprising of corticotropin compound (“Licensed Product”) in the United States and Canada (the “Territory”).”
AtriCure, Inc. amended First Amendment to Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, bookrunner and lead arranger, and the lenders party thereto (effective 2026-01-09).
“On January 9, 2026 (the “ Closing Date ”), AtriCure, Inc. (the “ Company ”) and its wholly owned subsidiary, AtriCure, LLC (together with the Company, the “ Borrowers ”), entered into a First Amendment (“ First Amendment ”) to Credit Agreement (as amended, the “ Credit Agreement ”) among the Borrowers, JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “ Administrative Agent ”), JPMorgan Chase Bank, N.A., as bookrunner and lead arranger (“ JPMCB ”), and the lenders party thereto (“ Lenders ”).”
KUSTOM ENTERTAINMENT, INC. entered into Unit Purchase Agreement with Nobility LLC valued at $1,450,000 (effective 2026-01-01).
“On January 8, 2026, Digital Ally Healthcare, Inc. (the “Seller”), a Nevada corporation and a wholly-owned subsidiary of Kustom Entertainment, Inc. (the “Company”) entered into and closed a Unit Purchase Agreement (the “Agreement”) with Nobility LLC, an Arizona limited liability company (the “Buyer”), and Nobility Healthcare, LLC, a Kansas limited liability company (“Nobility Healthcare” and collectively with the Seller and the Buyer the “Parties”). Pursuant to the Agreement, the Buyer purchased all of the Seller’s units of ownership interest (“Units”) in Nobility Healthcare, for Closing Funds (as defined in the Agreement) and a promissory note (the “Note”), totaling $ 1,450,000, due upon closing (the “Transaction”).”
AFS SENSUB CORP. entered into Underwriting Agreement with BofA Securities, Inc. (Representative), Deutsche Bank Securities Inc., Scotia Capital (USA) Inc., Wells Fargo Securities, LLC, Academy Securities, Inc., CIBC World Markets Corp., MUFG Securities Americas Inc., RBC Capital Markets, LLC (effective 2026-01-08).
“The Publicly Offered Notes will be sold to BofA Securities, Inc. (“ BofA Securities ” or the “ Representative ”), Deutsche Bank Securities Inc., Scotia Capital (USA) Inc., Wells Fargo Securities, LLC, Academy Securities, Inc., CIBC World Markets Corp., MUFG Securities Americas Inc. and RBC Capital Markets, LLC, pursuant to the Underwriting Agreement attached hereto as Exhibit 1.1 , dated as of January 8, 2026 (the “ Underwriting Agreement ”), among GM Financial, AFS SenSub and the Representative.”
SENTIENT BRANDS HOLDINGS INC. entered into addenda to existing Share Exchange Agreements with Aqua Emergency, Inc., AIG-F&B, Inc., and Wyoming Bears, Inc. (effective 2025-12-31).
“On December 31, 2025, the Company approved and authorized the execution of addenda to existing Share Exchange Agreements and related Drop-Ship Manufacturing Agreements for certain subsidiaries, including Aqua Emergency, Inc., AIG-F&B, Inc., and Wyoming Bears, Inc.”
Allegiant Travel CO entered into Agreement and Plan of Merger with Sun Country Airlines Holdings, Inc., Mirage Merger Sub, Inc., Sawdust Merger Sub, LLC (effective 2026-01-11).
“On January 11, 2026, Allegiant Travel Company, a Nevada corporation (“ Allegiant ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Sun Country Airlines Holdings, Inc., a Delaware corporation (“ Sun Country ”), Mirage Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Allegiant (“ Merger Sub 1 ”), and Sawdust Merger Sub, LLC, a Nevada limited liability company and a direct wholly owned subsidiary of Allegiant (“ Merger Sub 2 ”, together with Merger Sub 1, the “ Merger Subs ” )”
iRhythm Holdings, Inc. amended First Supplemental Indenture with U.S. Bank Trust Company, National Association valued at Modified conversion rights of 1.50% Convertible Senior Notes due 2024 to reference iRhythm Holdings (effective 2026-01-12).
“In connection with the Merger, on January 12, 2026, iRhythm, iRhythm Holdings, as guarantor, and U.S. Bank Trust Company, National Association (the “Trustee”), entered into a first supplemental indenture (the “Supplemental Indenture”) to the indenture, dated as of March 7, 2024, between iRhythm and the Trustee (the “Indenture”), governing iRhythm’s 1.50% Convertible Senior Notes (the “Convertible Notes")”
AMC ENTERTAINMENT HOLDINGS, INC. amended Supplemental Indenture with GLAS Trust Company LLC (effective 2025-01-12).
“AMC, Muvico, the other guarantors party thereto and GLAS Trust Company LLC, as trustee and notes collateral agent, entered into a supplemental indenture (the “Supplemental Indenture”) to the Exchangeable Notes Indenture to effectuate the Amendments.”
iBio, Inc. entered into Purchase Agreement with certain institutional investors valued at approximately $26 million (effective 2026-01-08).
“On January 8, 2026, iBio, Inc., a Delaware company (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors, in a private placement priced at-the-market consistent with the rules of the Nasdaq Stock Market LLC (the “Private Placement”) an aggregate of 1,408,481 shares (the “Shares”) of the Company’s common stock”
Cuentas Inc. entered into Limited Liability Company Agreement with Tummo Road LLC valued at $400,000 (effective 2026-01-07).
“On January 7, 2026, Cuentas, Inc. (the “Company”) entered into a Limited Liability Company Agreement (“LLC Agreement”) with Tummo Road LLC (“Tummo”) as members of World Mobile Media Group LLC”
National Healthcare Properties, Inc. amended Rights Agreement Amendment with Computershare Trust Company, N.A. (effective 2026-01-09).
“On January 9, 2026, the Company entered into Amendment No. 2 (the “Rights Agreement Amendment”) to its Rights Agreement solely to accelerate the expiration date of the Rights from May 18, 2026 to January 12, 2026.”
Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 aggregate principal amount (effective 2026-01-06).
“On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.”
Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 (effective 2026-01-05).
“On January 5, 2026 (the "Execution Date"), Jaguar Health, Inc. (the "Company") entered into securities purchase agreements (the "Securities Purchase Agreements") with two accredited investors (each, an "Investor"), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes”
Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 aggregate principal amount (effective 2026-01-06).
“On January 6, 2026 (the "Execution Date"), Jaguar Health, Inc. (the "Company") entered into securities purchase agreements (the "Securities Purchase Agreements") with two accredited investors (each, an "Investor"), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the "Notes") to such Investors.”
Gyrodyne, LLC amended Second Amendment with B2K Smithtown LLC valued at $1,520,222 (effective 2026-01-06).
“GSD Flowerfield LLC, a New York limited liability company (“GSD”) and wholly-owned subsidiary of Gyrodyne, LLC, a New York limited liability company (the “Company”), and B2K Smithtown LLC, a Delaware limited liability company (“B2K”), have entered into a Second Amendment dated as of January 6, 2026 (the “Second Amendment”) to the Purchase and Sale Agreement effective as of July 30, 2025 (the “Purchase Agreement”) between GSD and B2K.”
Ondas Inc. entered into Securities Purchase Agreement with each investor listed on the Schedule of Buyers attached thereto (effective 2026-01-09).
“The Common Stock Equivalents with the accompanying Common Warrants are being sold pursuant to the terms of a Securities Purchase Agreement, dated January 9, 2026 (the “Securities Purchase Agreement”), by and between the Company and each investor listed on the Schedule of Buyers attached thereto (the “Investor”) in connection with this Offering.”
Ondas Inc. entered into Placement Agent Agreement with Oppenheimer & Co. Inc. (effective 2026-01-09).
“On January 9, 2026, Ondas Holdings Inc. (the “Company” or “Ondas”) entered into a placement agent agreement (the “Placement Agent Agreement”) with Oppenheimer & Co. Inc., as representative of the placement agents named in Schedule I thereto (the “Placement Agents”), relating to the Company’s offering (the “Offering”) of (i) 19,000,000 shares (the “Shares”) of Company common stock, par value $0.0001 per share (“Common Stock”), or (ii) in lieu of Common Stock, pre-funded warrants (the “Pre-Funded Warrants,” together with the Shares, the “Common Stock Equivalents”) to purchase up to 41,790,274 shares of Common Stock (the “Pre-Funded Warrant Shares”).”
BEYOND MEAT, INC. entered into First Supplemental Indenture with Wilmington Trust, National Association (effective 2026-01-12).
“On January 12, 2026, Beyond Meat, Inc. (the “Company”) and Beyond Meat EU B.V., a wholly-owned subsidiary of the Company (the “New Guarantor”), entered into the First Supplemental Indenture (the “Supplemental Indenture”) with Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”) and collateral agent (in such capacity, the “Collateral Agent”).”
Optimum Communications, Inc. entered into Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at $1,100 million (effective 2026-01-12).
“On January 12, 2026, Cablevision Litchfield, LLC (“Cablevision Litchfield”) and CSC Optimum Holdings, LLC (“CSC Optimum”), each an indirect wholly-owned subsidiary of Optimum Communications, Inc., entered into an Amended and Restated Credit Agreement (the “A&R UnSub Credit Agreement”), by and among Cablevision Litchfield and CSC Optimum, each as a borrower, the guarantors party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent.”
Sun Country Airlines Holdings, Inc. entered into Agreement and Plan of Merger with Allegiant Travel Company valued at Per Share Cash Consideration: $4.10; Per Share Stock Consideration: 0.1557 shares of Allegiant commo (effective 2026-01-11).
“On January 11, 2026, Sun Country Airlines Holdings, Inc., a Delaware corporation (the “ Sun Country ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Allegiant Travel Company, a Nevada corporation (“ Allegiant ”), Mirage Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Allegiant (“ Merger Sub 1 ”), and Sawdust Merger Sub, LLC, a Nevada limited liability company and a direct wholly owned subsidiary of Allegiant (“ Merger Sub 2 ”, together with Merger Sub 1, the “ Merger Subs ”), providing for the merger of Merger Sub 1 with and into Sun Country (the “ First Merger ”), with Sun Country surviving the First Merger as a direct wholly owned subsidiary of Allegiant and immediately following the First Merger, the merger of Sun Country with and into Merger Sub 2 (the “ Second Merger ” and, together with the First Merger, the “ Mergers ”), with Merger Sub 2 surviving the Second Merger as a direct, wholly owned subsidiary of Allegiant”
TransMedics Group, Inc. entered into Lease with BioMed Realty valued at approximately $23.9 million (effective 2026-01-08).
“On January 8, 2026, TransMedics Group, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with BioMed Realty (the “Landlord”) for the lease of approximately 498,286 square feet of space located at 188 Assembly Park Drive, Somerville, MA 02145 (the “Premises”)”
Luminar Technologies, Inc./DE entered into Purchase Agreement with Quantum Computing Inc. valued at $22,000,000 (effective 2026-01-11).
“On January 11, 2026, the Company and certain of its affiliates (together, the “ Sellers ”) entered into a purchase agreement (the “ Purchase Agreement ”) with Quantum Computing Inc. (the “ Buyer ”) pursuant to which, subject to the terms and conditions set forth therein, the Buyer agreed to acquire specified assets related to the Sellers’ LiDAR business and assume certain liabilities (the “ Transaction ”), for cash consideration of $22,000,000.”
Osprey Bitcoin Trust amended Amendment to Third Amended and Restated Declaration of Trust and Trust Agreement with Delaware Trust Company valued at Amendment updates order placement time for Purchase and Redemption Orders from 6:00 p.m. to 5:30 p.m (effective 2026-01-09).
“On January 9, 2026, Osprey Funds, LLC, the sponsor (the “Sponsor”) of Osprey Bitcoin Trust (the “Trust”), and Delaware Trust Company entered into an amendment (the “Amendment”) to the Third Amended and Restated Declaration of Trust and Trust Agreement (the “Trust Agreement”) to update the order placement time of Purchase and Redemption Orders, as defined therein, from 6:00 p.m., Eastern Time on the Business Day prior to the trade date to 5:30 p.m. Eastern Time on the Business Day prior to the trade date for cash orders.”
SelectQuote, Inc. terminated Previous Credit Agreement with Ares Capital Corporation, as administrative agent, UMB Bank, N.A., as lender and revolver agent, and the other lenders party thereto (effective 2026-01-08).
“previous credit facility pursuant to the credit agreement, dated as of November 5, 2019, by and among the Company and Ares Capital Corporation, as administrative agent, UMB, as lender and revolver agent, and the other lenders party thereto (as amended, the “ Previous Credit Agreement ”), and for certain transaction expenses and fees. The remainder of the proceeds of the Term Loan will be used to support ongoing working capital needs and for general corporate purposes.”
SelectQuote, Inc. entered into Credit Agreement with PLC Agent LLC, as administrative agent, UMB Bank, N.A., as lender and revolver agent, and the other lenders party thereto valued at $325 million term loan and $90 million revolving credit facility (effective 2026-01-08).
“On January 8, 2026 (the “ Closing Date ”), SelectQuote, Inc. (the “ Company ”) entered into a credit agreement (the “ Credit Agreement ” or “ Agreement ”) with PLC Agent LLC, as administrative agent, UMB Bank, N.A. (“ UMB ”), as lender and revolver agent, and the other lenders party thereto.”
OS Therapies Inc entered into Inducement Letters with less than 10 accredited investors valued at approximately $7.5 million (effective 2026-01-10).
“On January 10, 2026, OS Therapies Incorporated (the “Company”) entered into inducement offer letter agreements (the “Inducement Letters”) with less than 10 accredited investors (the “Holders”)”
Belpointe PREP, LLC entered into Letter Agreement with Daniel Suozzi (effective 2026-01-06).
“On January 6, 2026 (the “Effective Date”), Belpointe PREP, LLC (the “Company”), 100 Tokeneke Partners, LLC, a Delaware limited liability company and indirect minority-owned subsidiary of the Company (“Tokeneke Partners”), and Daniel Suozzi (the “Suozzi”) entered into a Letter Agreement (the “Letter Agreement”) in connection with a transaction in which Suozzi contributed his indirect ownership interest in certain real property”
Nuvation Bio Inc. entered into License Agreement with Eisai Co., Ltd. valued at €50 million (effective 2026-01-11).
“On January 11, 2026, Nuvation Bio Inc. (the “Company”) entered into a License and Collaboration Agreement (the “License Agreement”) with Eisai Co., Ltd. (“Eisai”).”
Sky Quarry Inc. entered into Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. valued at up to $4,700,000 (effective 2026-01-12).
“On January 12, 2026, Sky Quarry Inc. (the “ Company ”) entered into a Controlled Equity Offering SM Sales Agreement (the “ Sales Agreement ”) with Cantor Fitzgerald & Co. (the “ Agent ”), pursuant to which the Company, from time to time, may offer and sell shares (the “ ATM Shares ”) of its common stock, par value $0.0001 per share (the “ Common Stock ”), through or to the Agent, acting as principal and/or sales agent, having an aggregate sales price of up to $4,700,000 (the “ ATM Offering ”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.